Healthcare -
Biotechnology - NASDAQ - US
$ 43.55
-2.09 %
$ 1.67 B
Market Cap
-14.19
P/E
Price Target
Average
48.11%
Revenue Forecast
Estimate
262.65%
EBIT
Estimate
34.52%
Net Income
Estimate
52.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Tarsus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for TARS of $64.5 , with forecasts ranging from
a
low of
$61 to a high of $72 .
TARS Lowest Price Target
Wall Street Target
61 USD
40.07%
TARS Average Price Target
Wall Street Target
64.5 USD
48.11%
TARS Highest Price Target
Wall Street Target
72 USD
65.33%
REVENUE FORECAST
Revenue Forecast Chart TARS
EBIT FORECAST
EBIT Forecast Chart TARS
NET INCOME FORECAST
Net Income Chart TARS